Abstract
Background
Congenital nephrotic syndrome is difficult to manage, particularly the Finnish type (CNF), with patients experiencing severe edema, sepsis and thrombosis before kidney transplantation. Further, nephrosis and thrombosis remain problematic after transplantation.
Methods
Of 22 CNF patients managed at our hospital, 14 who underwent kidney transplantation were retrospectively studied. CNF was diagnosed according to standard criteria.
Results
The study population consisted of 3 males and 11 females. Mean gestation period was 36 ± 1.4 weeks and mean birth weight was 2442 ± 454 g (mean placenta to body weight ratio: 0.4). All patients started dialysis at 2.4 ± 1.3 years and underwent kidney transplantation at 5.2 ± 2.0 years. The kidneys were donated by the parents (n = 13), and cadaver (n = 2), including overlap. Mean follow-up period after transplantation was 14.3 ± 8.9 years, and mean age at last observation was 19.5 ± 8.5 years. Two patients had recurrent proteinuria after kidney transplantation; one underwent retransplantation following graft failure and eventually required dialysis, while the second had complete remission after intensive immunosuppressive therapy. There were no cases of thrombosis or serious infections. Mean eGFR at the time of last observation was 57.3 ± 16.5 ml/min/1.73 m2, while mean height SD score was − 2.1 ± 0.9 at the time of transplantation and − 1.5 ± 1.5 at last observation.
Conclusions
Long-term outcome in these 14 CNF patients showed satisfactory graft survival, improved height SD score, and favorable development. Although recurrent proteinuria after transplant was not predictive, it was associated with graft survival rate.
Similar content being viewed by others
References
Arneil GC. The nephrotic syndrome. Pediatr Clin North Am. 1971;18:547–59.
Ahvenainen EK, Hallman N, Hjelt L. Nephrotic syndrome in newborn and young infants. Ann Paediatr Fenn. 1956;2:227–41.
Holmberg C, Laine J, Ronnholm K, Ala Houhala M, Jalanko H. Congenital nephrotic syndrome. Kidney Int Suppl. 1996;53:S51–6.
Albright SG, Warner AA, Seeds JW, Burton BK. Congenital nephrosis as a cause of elevated alpha-fetoprotein. Obstet Gynecol. 1990;76:969–71.
Mahan JD, Mauer SM, Sibley RK, Vernier RL. Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr. 1984;105:549–57.
Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein–nephrin–is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:575–82.
Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet. 1999;64:51–61.
Holmberg C, Antikainen M, Ronnholm K, Ala Houhala M, Jalanko H. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 1995;9:87–93.
Papez KE, Smoyer WE. Recent advances in congenital nephrotic syndrome. Curr Opin Pediat. 2004;16:165–70.
Pomeranz A, Wolach B, Bernheim J, Korzets Z, Bernheim J. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. J Pediatr. 1995;126:140–2.
Coulthard MG. Management of Finnish congenital nephrotic syndrome by unilateral nephrectomy. Pediatr Nephrol. 1989;3:451–3.
Heaton PA, Smales O, Wong W. Congenital nephrotic syndrome responsive to captopril and indometacin. Arch Dis Child. 1999;81:174–5.
Kovacevic L, Reid CJ, Rigden SP. Management of congenital nephrotic syndrome. Pediatr Nephrol. 2003;18:426–30.
Kim MS, Primack W, Harmon WE. Congenital nephrotic syndrome: preemptive bilateral nephrectomy and dialysis before renal transplantation. J Am Soc Nephrol. 1992;3:260–3.
Laine J, Jalanko H, Holthofer H, Krogerus L, Rapola J, von Willebrand E, et al. Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int. 1993;44:867–74.
Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, et al. Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation. 2002;73:394–403.
Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000;24:349–54.
Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A, et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet. 1998;62:824–33.
Sako M, Nakanishi K, Obana M, Yata N, Hoshii S, Takahashi S, et al. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int. 2005;67:1248–55.
Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626–33.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Kim MS, Stablein D, Harmon WE. Renal transplantation in children with congenital nephrotic syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1998;2:305–8.
Lane PH, Schnaper HW, Vernier RL, Bunchman TE. Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome. Pediatr Nephrol. 1991;5:300–3.
Flynn JT, Schulman SL, deChadarevian JP, Dunn SP, Kaiser BA, Polinsky MS, et al. Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. 1992;6:553–5.
Kuusniemi AM, Qvist E, Sun Y, Patrakka J, Ronnholm K, Karikoski R, et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation. 2007;83:1316–23.
Holmberg C, Jalanko H. Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol. 2014;29:2309–17.
Acknowledgements
The authors would like to thank Dr. Masahiro Ikeda.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Yuko Hamasaki belongs to a department endowed with sponsorship by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Astellas Pharma. The other authors have no potential conflicts of interest to disclose
Ethical approval
The study protocol conformed to the Declaration of Helsinki (2008) and was approved by the Toho University Omori Medical Center institutional ethics committees (approval number M16252) and the IRB of Tokyo Metropolitan Children’s Medical Center (approval number H29b-29).
About this article
Cite this article
Hamasaki, Y., Muramatsu, M., Hamada, R. et al. Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan. Clin Exp Nephrol 22, 719–726 (2018). https://doi.org/10.1007/s10157-017-1508-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-017-1508-4